Bansi Nagji - 02 Jun 2021 Form 4 Insider Report for GoodRx Holdings, Inc. (GDRX)

Role: President, Healthcare
Signature: /s/ Gracye Cheng, as Attorney-in-Fact for Bansi Nagji
Issuer symbol: GDRX
Transactions as of: 02 Jun 2021
Net transactions value: -$1,528,491
Form type: 4
Filing time: 07 Jun 2021, 06:03:14 UTC
Next filing: 11 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GDRX	Class A Common Stock	Options Exercise	$314,626	+45,998	+158%	$6.84	75,164	02 Jun 2021	Direct
transaction	GDRX	Class A Common Stock	Sale	$1,843,117	-45,998	-61%	$40.07^*	29,166	02 Jun 2021	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GDRX	Stock Option (Right to Buy)	Options Exercise	$0	-45,998	-6.9%	$0.000000	624,836	02 Jun 2021	Class A Common Stock	45,998	$6.84	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2	This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3	The option has vested and became exercisable or will vest and become exercisable with respect to the original 670,834 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on June 10, 2020.